Enanta Pharmaceuticals reported $18.72M in Sales Revenues for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Acorda Therapeutics ACOR:US $ 31.05M 8.52M
Amgen AMGN:US $ 6594M 356M
Anika Therapeutics ANIK:US $ 39.66M 2.96M
Arrowhead Research ARWR:US $ 32.41M 119.39M
AstraZeneca AZN:LN 10771M 619M
Biocryst Pharmaceuticals BCRX:US $ 65.53M 15.61M
Biogen BIIB:US $ 2589.1M 57.3M
Bristol Myers Squibb BMY:US $ 11887M 239M
Clovis Oncology CLVS:US $ 34.25M 1.72M
Enanta Pharmaceuticals ENTA:US $ 18.72M 8.93M
Gilead Sciences GILD:US $ 6260M 330M
GlaxoSmithKline GSK:LN 6929M 2851M
Halozyme Therapeutics HALO:US $ 117.28M 15.28M
Heron Therapeutics HRTX:US $ 23.46M 2.8M
Insmed INSM:US $ 65.22M 12.11M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
IONIS PHARMACEUT IONS:US $ 141.92M 298.09M
Johnson & Johnson JNJ:US $ 24020M 594M
Karyopharm Therapeutics KPTI:US $ 39.68M 7.99M
Ligand Pharmaceuticals LGND:US $ 45.69M 26.78M
Marinus Pharmaceuticals MRNS:US 14.19M 12.67M
Merk MRK:US $ 14593M 1308M
Neurocrine Biosciences NBIX:US $ 378.2M 67.6M
Novartis NOVN:VX SF 13085M 271M
Novavax NVAX:US $ 703.97M 481.77M
Pfizer PFE:US $ 27742M 2081M
Ptc Therapeutics PTCT:US $ 165.53M 16.79M
Roche Holding ROG:VX 16.44B 474M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Vertex Pharmaceuticals VRTX:US $ 2196.2M 98.7M
YTE INCY:US $ 911.4M 178.16M